Literature DB >> 33861456

Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review.

Farshad Abedi Torbati1, Mahin Ramezani2, Reza Dehghan1, Mohammad Sadegh Amiri3, Ali Tafazoli Moghadam4,5, Neda Shakour6, Sepideh Elyasi7, Amirhossein Sahebkar8,9,4,10, Seyed Ahmad Emami11.   

Abstract

Centella asiatica (CA) or Gotu cola is an herbal plant from the Apiaceae family with a long history of usage in different traditional medicines. It has long been used for the treatment of various ailments such as central nervous system (CNS), skin and gastrointestinal disorders especially in the Southeast Asia. This chapter focused on the phytochemical constituent and pharmacological activities of CA based on preclinical and clinical studies. Additionally, botanical description and distribution, traditional uses, interactions, and safety issues are reviewed. Electronic databases of Google Scholar, Scopus, PubMed, and Web of Science were searched to obtain relevant studies on the pharmacological activities of CA. Approximately, 124 chemical compounds including triterpenoids, polyphenolic compounds, and essential oils have been isolated and identified from CA. Ethnomedicinal applications of CA mostly include treatment of gastrointestinal diseases, wounds, nervous system disorders, circulatory diseases, skin problems, respiratory ailments, diabetes and sleep disorders in various ethnobotanical practices. Pharmacological studies revealed a wide range of beneficial effects of CA on CNS, cardiovascular, lung, liver, kidney, gastrointestinal, skin, and endocrine system. Among them, neuroprotective activity, wound healing and treatment of venous insufficiency, as well as antidiabetic activity seem to be more frequently reported. At the moment, considering various health benefits of CA, it is marketed as an oral supplement as well as a topical ingredient in some cosmetic products. Additional preclinical studies and particularly randomized controlled trials are needed to clarify the therapeutic roles of CA.

Entities:  

Keywords:  Centella asiatica; Clinical studies; Ethnobotany; Herbal plant; Pharmacology; Phytochemistry

Mesh:

Substances:

Year:  2021        PMID: 33861456     DOI: 10.1007/978-3-030-64872-5_25

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  153 in total

1.  Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study.

Authors:  L Incandela; G Belcaro; M R Cesarone; M T De Sanctis; E Nargi; P Patricelli; M Bucci
Journal:  Angiology       Date:  2001-10       Impact factor: 3.619

2.  Hypolipidemic and hypoglycemic effects of Centella asiatica (L.) extract in vitro and in vivo.

Authors:  Nattapon Supkamonseni; Aree Thinkratok; Duangdeun Meksuriyen; Rungrudee Srisawat
Journal:  Indian J Exp Biol       Date:  2014-10       Impact factor: 0.818

3.  A clinical study on the management of generalized anxiety disorder with Centella asiatica.

Authors:  U Jana; T K Sur; L N Maity; P K Debnath; D Bhattacharyya
Journal:  Nepal Med Coll J       Date:  2010-03

Review 4.  Chemical structures, production and enzymatic transformations of sapogenins and saponins from Centella asiatica (L.) Urban.

Authors:  Robert Azerad
Journal:  Fitoterapia       Date:  2016-08-01       Impact factor: 2.882

5.  Centella asiatica ameliorates diabetes-induced stress in rat tissues via influences on antioxidants and inflammatory cytokines.

Authors:  Bubuya Masola; Oluwafemi O Oguntibeju; Ayodeji B Oyenihi
Journal:  Biomed Pharmacother       Date:  2018-03-22       Impact factor: 6.529

6.  [The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study].

Authors:  M R Cesarone; G Laurora; M T De Sanctis; L Incandela; R Grimaldi; C Marelli; G Belcaro
Journal:  Minerva Cardioangiol       Date:  1994-06       Impact factor: 1.347

7.  Long-term follow-up of oral administration of flavonoids, Centella asiatica and Melilotus, for diabetic cystoid macular edema without macular thickening.

Authors:  Raimondo Forte; Gilda Cennamo; Paola Bonavolontà; Arduino Pascotto; Giuseppe de Crecchio; Giovanni Cennamo
Journal:  J Ocul Pharmacol Ther       Date:  2013-07-11       Impact factor: 2.671

8.  Comparison of Flavonoids and Centella asiatica for the treatment of chronic anal fissure. A randomized clinical trial.

Authors:  Massimo Chiaretti; Danilo Alunni Fegatelli; Giancarlo Ceccarelli; Giovanna Angela Carru; Giuseppe Pappalardo; Annalisa Italia Chiaretti
Journal:  Ann Ital Chir       Date:  2018       Impact factor: 0.766

9.  Centella asiatica enhances hepatic antioxidant status and regulates hepatic inflammatory cytokines in type 2 diabetic rats.

Authors:  Ayodeji B Oyenihi; Novel N Chegou; Oluwafemi O Oguntibeju; Bubuya Masola
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 10.  Discovery and resupply of pharmacologically active plant-derived natural products: A review.

Authors:  Atanas G Atanasov; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Thomas Linder; Christoph Wawrosch; Pavel Uhrin; Veronika Temml; Limei Wang; Stefan Schwaiger; Elke H Heiss; Judith M Rollinger; Daniela Schuster; Johannes M Breuss; Valery Bochkov; Marko D Mihovilovic; Brigitte Kopp; Rudolf Bauer; Verena M Dirsch; Hermann Stuppner
Journal:  Biotechnol Adv       Date:  2015-08-15       Impact factor: 14.227

View more
  4 in total

1.  Identification of Asiaticoside from Centella erecta (Apiaceae) as Potential Apyrase Inhibitor by UF-UHPLC-MS and Its In Vivo Antischistosomal Activity.

Authors:  Lara Soares Aleixo de Carvalho; Vinícius Carius de Souza; Vinícius C Rodrigues; Aline Correa Ribeiro; Jorge Willian Leandro Nascimento; Priscila V S Z Capriles; Priscila de F Pinto; Josué de Moraes; Ademar Alves da Silva Filho
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

Review 2.  Traditional Chinese Medicine Regulates Th17/Treg Balance in Treating Inflammatory Bowel Disease.

Authors:  Fengjiao Xie; Qin Xiong; Yilin Li; Chengjiao Yao; Ruike Wu; Qiuxiang Wang; Lihong Luo; Hongling Liu; Peimin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-15       Impact factor: 2.650

Review 3.  NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2021-05-14

Review 4.  Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease.

Authors:  Jia Hui Wong; Anna M Barron; Jafri Malin Abdullah
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.